黑丘疹皮肤病 (DPN) 是一种非癌性皮肤生长物，被归类为脂溢性角化病的亚型。 DPN 主要见于肤色较深的个体，即菲茨帕特里克皮肤类型 III-VI 的个体。这种情况主要影响亚裔或非裔美国人后裔的女性。无法对这种疾病进行准确的治疗给医学界带来了挑战。 电干燥、激光疗法和手术提供了昂贵的解决方案。悉达外药通过适当的方法提供了解决方案。一名 70 岁的 Fitzpatrick V 型皮肤女性，颧骨处出现许多色素沉着过度的丘疹，这些丘疹已存在五年了。皮肤科检查发现存在数个棕色丘疹性病变，在颧骨区域尤其明显。病变的尺寸通常为 1 至 5 毫米；然而，在颧骨区域，它们的尺寸扩大到1厘米。 Siddha 配方 Pachaieruvai 连续五天外部给药。在接受治疗时，患者在使用Pachaieruvai的部位出现轻微疼痛、烧灼感、轻微红肿。这些症状在手术期间和手术后持续约一个小时，但在使用椰子油后 24 小时内消失。治疗反应的评估是使用公认的四分位数分级方法确定的。在最后一次治疗后的第一周随访中，观察到脸颊皮损明显改善，特别是四个大皮损。在整个治疗过程中，患者可能会感到轻微不适，烧灼感，轻微红肿。 Pachaieruwai 的管理站点。这些反应是疾病消退的积极指标。随访期间未观察到不良症状和复发。本研究专门研究了 Siddha 管理 DPN 的方法。根据研究结果和观察，可以得出结论，Siddha 药物对治疗 DPN 有效。版权所有 © 2024，Karan Chand Mohan Singh 等人。

Dermatosis papulosa nigra (DPN) is a noncancerous skin growth that is classified as a subtype of seborrhoeic keratoses. DPN is predominantly found in individuals with darker skin tones, namely, those with Fitzpatrick skin types III-VI. This condition primarily affects women of Asian or African American descent. The non-availability of accurate management for this illness presents a challenge to the medical fraternity. Electrodesiccation, laser therapy, and surgery offer expensive solutions. Siddha external medicine provides a solution through appropriate methods. A 70-year-old woman with Fitzpatrick skin type V appeared with many hyperpigmented papules on the malar region that had been present for five years. The dermatological examination revealed the presence of several brown papular lesions, which were particularly pronounced in the malar areas. The dimensions of the lesions typically varied from 1 to 5 mm; however, in the malar area, their size extended up to 1 cm. The Siddha formulation Pachaieruvai was administered externally for five consecutive days. While undergoing treatment, the patient experienced mild pain, burning, slight redness, and swelling in the area where Pachaieruvai was applied. These symptoms persisted for about an hour during and after the procedure but disappeared within 24 hours with the use of coconut oil. The evaluation of treatment response was determined using the recognised quartile grading methodology. During the first-week follow-up appointment after the last treatment, significant improvements were observed in the cheek lesions, particularly in four large lesions.Throughout the treatment, the patient may encounter mild discomfort, a burning sensation, slight redness, and swelling at the administration site of Pachaieruvai. These reactions are positive indicators of disease regression. No adverse symptoms and recurrence were observed during the follow-up. This research specifically examines the Siddha approach to managing DPN. Based on the findings and observations, it can be concluded that Siddha medicine is effective in treating DPN.Copyright © 2024, Karan Chand Mohan Singh et al.